Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Fresenius Dialysis Lawsuits Continue to Mount As MDL Considered February 13, 2013 Austin Kirk Add Your Comments A growing number of a personal injury and wrongful death lawsuits are being filed against Fresenius Medical Care throughout the country, alleging that individuals suffered sudden cardiac arrest or heart attacks following dialysis treatment involving the company’s Granuflo or NaturaLyte solutions. According to recent court filings, dozens of new Fresenius dialysis lawsuits have been filed in recent months, and it is expected the litigation could eventually include thousands of lawsuits. In December 2012, a group of plaintiffs filed a request with the U.S. Judicial Panel on Multidistrict Litigation (JPML) asking that all Fresenius lawsuits filed in U.S. District Courts throughout the country be consolidated for pretrial proceedings as part of an MDL, or multidistrict litigation. At that time, there were only 11 complaints identified in the federal court system involving injuries allegedly caused by side effects of Granuflo or NaturaLyte dialysis treatments. Learn More About Fresenius Dialysis Treatment Lawsuit Heart attacks, deaths during hemodialysis may be caused by Granuflo, NaturaLyte. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Fresenius Dialysis Treatment Lawsuit Heart attacks, deaths during hemodialysis may be caused by Granuflo, NaturaLyte. Learn More SEE IF YOU QUALIFY FOR COMPENSATION By the first week of January 2013, when Fresenius filed a response supporting the establishment of an MDL for the dialysis lawsuits, the manufacturer indicated that the number of pending cases had already increased to 37, and that a substantial number of additional complaints were expected in the future. In a Schedule of Actions (PDF) filed with the U.S. JPML on February 12, plaintiffs who filed a response supporting the establishment of the Fresenius dialysis MDL now indicate that there are at least 59 potentially related actions pending in U.S. District Courts throughout the United States. In addition, a law firm representing a separate group of plaintiffs filed another response (PDF) indicating that the current actions are only the “tip of the iceberg” and that hundreds of potential Granuflo and NaturaLyte lawsuits are being investigated by that one firm alone. Litigation over Fresenius Dialysis Treatments All of the lawsuits involve similar allegation, claiming that the company failed to provide adequate warnings about the risk of complications during Granuflu or Naturalyte dialysis treatment, including the importance of monitoring patients’ bicarbonate levels to avoid a risk of sudden cardiac arrest or death. NaturaLyte is a liquid acid concentrate and GranuFlo is a dry acid concentrate. Both products contain sodium acetate that allegedly converts to bicarbonate at higher-than-expected levels for most doctors, according to allegations raised in the complaints. Fresenius Medical Care not only manufactures these dialysis solutions and other products used at clinics throughout the United States, but they also own and operate thousands of dialysis clinics throughout the United States. Plaintiffs allege that Fresenius not only knew about the problems with dialysis treatment involving Granuflo and NaturaLyte, but withheld that information from doctors at clinics nationwide who were using the products, exposing patients to a substantial risk of serious and life-threatening injury. According to an internal memo sent to their own clinics in November 2011, Fresenius conducted a review of patients treated at 667 of their own clinics in 2010 and found at least 941 instances where individuals suffered cardiac arrest during dialysis treatment. The memo warned physicians at Fresenius clinics about the importance of monitoring bicarbonate levels, but the company failed to provide this information to other clinics that used Granuflo and NaturaLyte. After the internal memo was leaked to the FDA in March 2012, Fresenius finally provided a warning letter to all healthcare providers, which the FDA has classified as a NaturaLyte and Granuflo recall. Fresenius Dialysis MDL Hearing As the number of Fresenius dialysis complaints continues to increase throughout the country, the U.S. JPML is expected to hear oral arguments on the MDL motion on March 21 in San Diego, at the next hearing session. Although nearly all of the parties involved in the litigation agree that the lawsuits should be consolidated to reduce duplicative discovery, avoid conflicting pretrial rulings from different judges and serve the convenience of the witnesses, parties and the courts, there is some disagreement about where the Fresnius litigation should be centralized. In the original motion filed, it was suggested that the MDL be centralized in the U.S. District Court for the District of Massachusetts. In the response filed by Fresenius, the defendant supported transferring all cases to Massachusetts, which is where the company’s principal place of business is located, and where most of the documents and witnesses common to all cases are located. However, competing proposals have been filed by interested parties suggesting that the litigation be transferred to the Southern District of Mississippi or Northern District of Alabama, pointing out that the greatest number of cases are located in the southeastern U.S. Tags: Dialysis, Fresenius, Granuflo, Heart Attack, NaturaLyte, Wrongful Death More Fresenius Dialysis Lawsuit Stories DaVita Dialysis Lawsuit Over Cardiac Arrests Results in $383.5M Verdict June 28, 2018 Fresenius Dialysis Trial Results in Defense Verdict After Opting Out of Settlement March 6, 2017 Lawsuit Over Fresenius Dialysis Treatments Filed by Kentucky A.G. September 7, 2016 1 Comments Brian March 15, 2013 i am a renal failure patient at fresenius. the people are great but i have ABSOLUTELY had some of these effects theyre speaking of: I was in a-fib for 13 days nov-dec 2012 and have irregular heartbeat now as well as a small tremor/tick thats pretty constant now. The point of dialysis is to keep you healthy until you can get a kidney and go on with your life. NOT to give you more chronic problems. Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermCommentsThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES 6 Bard PowerPort Lawsuits Selected for Bellwether Trials in Federal MDL (Posted: today) A federal judge has identified the six Bard PowerPort lawsuits that will serve as the first bellwether trials, to test allegations that the port catheters were defectively designed. MORE ABOUT: BARD POWERPORT LAWSUITCourt Indicates Bard PowerPort MDL Bellwether Lawsuits Should Include 3 Infection, 2 Thrombosis and 1 Fracture Case (05/06/2025)Lawyers Proposed 11 Bard Implantable Port Catheter Lawsuits as Bellwether Trial Candidates (04/30/2025)Bard PowerPICC Intravascular Catheter Leaks Linked to Reports of Serious Injuries: FDA (04/21/2025) MDL Judge Orders Paraquat Lawsuit Settlement Update By June 11, 2025 (Posted: 3 days ago) A federal judge has agreed to stay all case-specific discovery deadlines in Paraquat lawsuits, while the parties work to hammer out a settlement agreement to resolve thousands of claims. MORE ABOUT: PARAQUAT PARKINSON’S DISEASE LAWSUITSParaquat Settlement Reached for Parkinson’s Disease Lawsuits Filed in MDL (04/16/2025)Appeals Court Urged To Reinstate Paraquat Lawsuits Previously Set for Bellwether Trials (02/14/2025)Paraquat Lawsuits Over Parkinson’s Disease Risk Set for Trial in October 2025, April 2026 (01/29/2025) Court Outlines Requirements for Depo-Provera Lawsuit Proof of Use, Type of Meningioma Tumor (Posted: 4 days ago) As new Depo-Provera lawsuits continue to be filed, the judge presiding over the litigation has established key criteria for establishing proof of Depo-Provera use and medical documentation confirming a meningioma diagnosis. MORE ABOUT: DEPO-PROVERA LAWSUITDepo Shot Lawsuit Filed Over Serious Brain Tumor Injuries (05/07/2025)Lawsuit Alleges Depo-Provera Migraines, Headaches Led to Meningioma Brain Tumor Diagnosis (05/01/2025)Depo-Provera Hearing Loss Lawsuit Filed Over Brain Tumor Side Effects (04/22/2025)
6 Bard PowerPort Lawsuits Selected for Bellwether Trials in Federal MDL (Posted: today) A federal judge has identified the six Bard PowerPort lawsuits that will serve as the first bellwether trials, to test allegations that the port catheters were defectively designed. MORE ABOUT: BARD POWERPORT LAWSUITCourt Indicates Bard PowerPort MDL Bellwether Lawsuits Should Include 3 Infection, 2 Thrombosis and 1 Fracture Case (05/06/2025)Lawyers Proposed 11 Bard Implantable Port Catheter Lawsuits as Bellwether Trial Candidates (04/30/2025)Bard PowerPICC Intravascular Catheter Leaks Linked to Reports of Serious Injuries: FDA (04/21/2025)
MDL Judge Orders Paraquat Lawsuit Settlement Update By June 11, 2025 (Posted: 3 days ago) A federal judge has agreed to stay all case-specific discovery deadlines in Paraquat lawsuits, while the parties work to hammer out a settlement agreement to resolve thousands of claims. MORE ABOUT: PARAQUAT PARKINSON’S DISEASE LAWSUITSParaquat Settlement Reached for Parkinson’s Disease Lawsuits Filed in MDL (04/16/2025)Appeals Court Urged To Reinstate Paraquat Lawsuits Previously Set for Bellwether Trials (02/14/2025)Paraquat Lawsuits Over Parkinson’s Disease Risk Set for Trial in October 2025, April 2026 (01/29/2025)
Court Outlines Requirements for Depo-Provera Lawsuit Proof of Use, Type of Meningioma Tumor (Posted: 4 days ago) As new Depo-Provera lawsuits continue to be filed, the judge presiding over the litigation has established key criteria for establishing proof of Depo-Provera use and medical documentation confirming a meningioma diagnosis. MORE ABOUT: DEPO-PROVERA LAWSUITDepo Shot Lawsuit Filed Over Serious Brain Tumor Injuries (05/07/2025)Lawsuit Alleges Depo-Provera Migraines, Headaches Led to Meningioma Brain Tumor Diagnosis (05/01/2025)Depo-Provera Hearing Loss Lawsuit Filed Over Brain Tumor Side Effects (04/22/2025)